欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/2591/002
药品名称Erlotinib Teva B.V.
活性成分
    • erlotinib 100.0 mg
剂型Film-coated tablet
上市许可持有人Teva B.V. Swensweg 5 2031 GA Haarlem The Netherlands
参考成员国 - 产品名称Denmark (DK)
Erlotinib Teva B.V.
互认成员国 - 产品名称
    • Germany (DE)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Greece (GR)
    • Estonia (EE)
      ERLOTINIB ACTAVIS
    • Hungary (HU)
      ERLOTINIB ACTAVIS 100 mg filmtabletta
    • Bulgaria (BG)
    • Czechia (CZ)
    • Slovakia (SK)
    • Slovenia (SI)
许可日期2017/05/04
最近更新日期2023/12/21
药物ATC编码
    • L01XE03 erlotinib
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase